Holmes D R, Gersh B J, Bailey K R, Reeder G S, Bresnahan J F, Bresnahan D R, Vlietstra R E
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, MN 55905.
Circulation. 1990 Mar;81(3 Suppl):IV51-6.
Although thrombolytic therapy has been a major advance in the treatment of acute myocardial infarction, in at least 25% of patients the artery remains occluded after administration. In these patients, the strategy of "rescue" or "salvage" angioplasty is frequently used although follow-up data are limited. Sixty-three patients underwent percutaneous transluminal coronary angioplasty (PTCA) after thrombolytic therapy for acute myocardial infarction. The decision to proceed with PTCA was based on physician preference and not a specific research protocol. In 34 of these selected patients, PTCA was performed as a rescue procedure because the infarct-related artery remained occluded (group 1); in 29 of these patients, it was performed to treat a severe but subtotal residual stenosis (group 2). PTCA successfully restored patency in 71% of group 1 and in 90% of group 2. Group 1 patients had a significantly worse baseline ejection fraction than did those in group 2 (47 +/- 13% vs. 58 +/- 13%, p = 0.0015). Group 1 patients also had a significantly worse predismissal ejection fraction (36 +/- 13% vs. 50 +/- 14%, p = 0.0004). During initial hospitalization, 14 (22%) patients underwent coronary bypass surgery. In-hospital mortality was low in each group (3% in group 1 and 0% in group 2). During a mean follow-up of 4 years, 89% of group 1 patients remained alive as compared with 97% of group 2 patients. This excellent 4-year survival rate, despite the depressed predismissal ejection fraction in patients undergoing rescue PTCA, raises the issue of whether acute reperfusion has a beneficial effect aside from any impact on myocardial salvage and preservation of left ventricular function.
尽管溶栓疗法在急性心肌梗死的治疗方面取得了重大进展,但至少25%的患者在用药后动脉仍处于闭塞状态。在这些患者中,尽管随访数据有限,但“补救”或“挽救”性血管成形术策略仍被频繁使用。63例急性心肌梗死患者在接受溶栓治疗后接受了经皮腔内冠状动脉成形术(PTCA)。进行PTCA的决定基于医生的偏好,而非特定的研究方案。在这些选定的患者中,34例患者因梗死相关动脉仍闭塞而将PTCA作为补救措施(第1组);在另外29例患者中,进行PTCA是为了治疗严重但不完全的残余狭窄(第2组)。PTCA在第1组71%的患者和第2组90%的患者中成功恢复了血管通畅。第1组患者的基线射血分数明显低于第2组患者(47±13%对58±13%,p = 0.0015)。第1组患者出院前的射血分数也明显更低(36±13%对50±14%,p = 0.0004)。在初次住院期间,14例(22%)患者接受了冠状动脉搭桥手术。每组的住院死亡率都很低(第1组为3%,第2组为0%)。在平均4年的随访期间,第1组89%的患者存活,而第2组为97%。尽管接受补救性PTCA的患者出院前射血分数较低,但这一出色的4年生存率引发了一个问题,即除了对心肌挽救和左心室功能保存的任何影响外,急性再灌注是否具有有益作用。